Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

Clinical trial NCT00107952 · COMPLETED

Trial details

NCT number: NCT00107952
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Pneumonia

Start date: 2005-02-01
Primary completion: 2007-07-01
Enrollment: 761

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.